Stable In‐Hospital Mortality Despite Increasing Thrombectomy Use in Young Adults With Ischemic Stroke: A Nationwide Study in Spain (2016–2022)
European Journal of Neurology · 2026-11 · 33 (11)
DOI: 10.1111/ene.70789 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 19.11.2026. Verfasst von Tania Garrido‐Hernández und 2 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Ischemic stroke (IS) in young adults is increasing in incidence and carries a disproportionate socioeconomic burden. The adoption of reperfusion therapies, particularly mechanical thrombectomy, has transformed stroke care; however, their impact on mortality in this low‐risk population remains uncertain.
Methods
We performed a nationwide, population‐based retrospective study using the Spanish Minimum Basic Data Set (MBDS), including all hospital admissions for IS in patients aged 18–50 years from 2016 to 2022. Temporal trends in admissions, reperfusion therapies, and in‐hospital mortality were assessed. Independent predictors of mortality were identified using multivariable logistic regression.
Results
Among 20,533 admissions, the number of hospitalizations increased over time, accompanied by a rise in reperfusion therapies. Mechanical thrombectomy rates nearly doubled from 6.3% in 2016 to 12.1% in 2022 ( p < 0.001). Despite this expansion, in‐hospital mortality remained low and stable throughout the study period (2.8%). Mortality was independently associated with malignant neoplasm (OR 8.45), followed by orotracheal intubation (OR 4.85), coma (OR 3.73), cerebral edema (OR 2.16), acute kidney injury (OR 1.85), acute respiratory failure (OR 1.38), posterior circulation stroke (OR 1.42), and All Patient Refined Diagnosis Related Groups (APR‐DRG) mortality risk level (all p < 0.001).
Conclusions
In young adults with IS, the expansion of reperfusion therapies was not associated with reduced in‐hospital mortality, which remained low over time. Malignant neoplasm was the strongest independent predictor of death, followed by acute neurological complications and organ dysfunction. These findings highlight the need for further multicentre clinical research to better understand the causes of death in young adults with IS.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Garrido‐Hernández, T., Amaya‐Pascasio, L., & Martínez‐Sánchez, P. (2026). Stable In‐Hospital Mortality Despite Increasing Thrombectomy Use in Young Adults With Ischemic Stroke: A Nationwide Study in Spain (2016–2022). European Journal of Neurology, 33(11). https://doi.org/10.1111/ene.70789
Vancouver
Garrido‐Hernández T, Amaya‐Pascasio L, Martínez‐Sánchez P. Stable In‐Hospital Mortality Despite Increasing Thrombectomy Use in Young Adults With Ischemic Stroke: A Nationwide Study in Spain (2016–2022). European Journal of Neurology. 2026;33(11). doi:10.1111/ene.70789
BibTeX
@article{GarridoHernndez2026,
author = {Garrido‐Hernández, Tania and Amaya‐Pascasio, Laura and Martínez‐Sánchez, Patricia},
title = {Stable In‐Hospital Mortality Despite Increasing Thrombectomy Use in Young Adults With Ischemic Stroke: A Nationwide Study in Spain (2016–2022)},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {11},
doi = {10.1111/ene.70789}
}
EUVIMED